MANDAL; Jayanta Kumar
Patent Applications and Registrations
Patent applications and USPTO patent grants for MANDAL; Jayanta Kumar.The latest application filed is for "liquid oral formulations for tadalafil".
Company Profile
14.8.41
- MANDAL; Jayanta Kumar - Ahmedabad IN
- MANDAL; Jayanta Kumar - Ahmedabad Gujarat IN
- MANDAL; Jayanta Kumar - Satellite IN
- Mandal; Jayanta Kumar - Gujarat IN
- Mandal; Jayanta Kumar - Satelite Ahmedabad
- MANDAL; Jayanta Kumar - Ramdev Nagar Satelite
Patent Activity
| Patent | Date |
|---|---|
| Liquid Oral Formulations For Tadalafil App 20220296602 - PANDYA; Jinal ; et al. | 2022-09-22 |
| Pharmaceutical Formulations Comprising Diclofenac App 20220280463 - MANDAL; Jayanta Kumar ; et al. | 2022-09-08 |
| Aqueous Suspension Suitable For Oral Administration App 20220280421 - MEHTA; Sandip P. ; et al. | 2022-09-08 |
| Pharmaceutical Solution Of Amlodipine App 20220241195 - MANDAL; Jayanta Kumar ; et al. | 2022-08-04 |
| Liquid oral formulations for tadalafil Grant 11,382,917 - Pandya , et al. July 12, 2 | 2022-07-12 |
| Oral Pharmaceutical Composition Comprising Zonisamide And Process Of Preparation Thereof App 20220202782 - Nagar; Swati ; et al. | 2022-06-30 |
| Aqueous suspension suitable for oral administration Grant 11,369,567 - Mehta , et al. June 28, 2 | 2022-06-28 |
| Liquid Dosage Forms Of Imatinib App 20220160709 - MEHTA; Sandip ; et al. | 2022-05-26 |
| Liquid oral formulations for sildenafil Grant 11,337,979 - Pandya , et al. May 24, 2 | 2022-05-24 |
| Stable Parenteral Dosage Form Of Pyrazolone Derivative App 20220105000 - MANDAL; Jayanta Kumar ; et al. | 2022-04-07 |
| Pharmaceutical solution of amlodipine Grant 11,253,474 - Mandal , et al. February 22, 2 | 2022-02-22 |
| Liquid Oral Formulations For Pde V Inhibitors App 20210393635 - PANDYA; Jinal ; et al. | 2021-12-23 |
| Liquid Oral Formulations For Pde V Inhibitors App 20210369717 - PANDYA; Jinal ; et al. | 2021-12-02 |
| Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agents Grant 11,147,810 - Mehta , et al. October 19, 2 | 2021-10-19 |
| Pharmaceutical composition of pemetrexed Grant 11,147,817 - Mandal , et al. October 19, 2 | 2021-10-19 |
| Liquid Compositions Of Aprepitant App 20210213024 - NAGAR; SWATI ; et al. | 2021-07-15 |
| Pharmaceutical Composition Of Pemetrexed App 20210100804 - MANDAL; Jayanta Kumar ; et al. | 2021-04-08 |
| Liquid Parenteral Compositions Of Levothyroxine App 20210059967 - PARIKH; Kinjal ; et al. | 2021-03-04 |
| Liquid Oral Formulations For Pde V Inhibitors App 20210052591 - PANDYA; Jinal ; et al. | 2021-02-25 |
| Liquid Dosage Forms Of Cinacalcet Or Salt Thereof App 20210030671 - NAGAR; Swati ; et al. | 2021-02-04 |
| Pharmaceutical Composition Of Oral Suspension Of Immunosuppressive Agents App 20200246261 - Kind Code | 2020-08-06 |
| Liquid Dosage Forms Of Imatinib App 20200206223 - MEHTA; Sandip ; et al. | 2020-07-02 |
| Pre-mixed, Ready To Use Vancomycin Compositions App 20200188478 - CHANDARANA; Dhaval ; et al. | 2020-06-18 |
| Pharmaceutical Composition Of Oral Suspension Of Anti-neoplastic Alkylating Agents App 20200069678 - MEHTA; Sandip ; et al. | 2020-03-05 |
| Method For Preparation Of Liquid Oral Composition Of L-thyroxin App 20200046664 - PATEL; Vijay ; et al. | 2020-02-13 |
| Pharmaceutical Composition Of Oral Solution Of Muscarinic Antagonist App 20200022910 - MEHTA; Sandip ; et al. | 2020-01-23 |
| Composition Comprising Bortezomib App 20190290718 - Mandal; Jayanta Kumar ; et al. | 2019-09-26 |
| Oral Pharmaceutical Composition Comprising Zonisamide And Process Of Preparation Thereof App 20190209529 - NAGAR; Swati ; et al. | 2019-07-11 |
| Pharmaceutical Composition Comprising An Androgen Receptor Inhibitor App 20190209469 - PATEL; Nileshkumar Bhikhabhai ; et al. | 2019-07-11 |
| Composition comprising bortezomib Grant 10,314,880 - Kanteepan , et al. | 2019-06-11 |
| A Novel Pharmaceutical Composition Of A Lipid Lowering Compound App 20190142741 - MEHTA; Sandip P. ; et al. | 2019-05-16 |
| Oral Solution Of Ace Inhibitors App 20180325813 - Mandal; Jayanta Kumar ; et al. | 2018-11-15 |
| Oral Solution Of Dihydropyridine Derivatives App 20180303811 - Mandal; Jayanta Kumar ; et al. | 2018-10-25 |
| Pharmaceutical Composition Of Teriflunomide App 20180147148 - SATPATHY; Tarun Kumar ; et al. | 2018-05-31 |
| Pharmaceutical Composition Of Pemetrexed App 20170340639 - Mandal; Jayanta Kumar ; et al. | 2017-11-30 |
| Composition Comprising Bortezomib App 20170035831 - Kanteepan; P. ; et al. | 2017-02-09 |
| Pharmaceutically Acceptable Dosage Form Comprising Release Of Multiple Drugs From Single Oral Dosage Form App 20150328165 - MANDAL; Jayanta Kumar ; et al. | 2015-11-19 |
| Stable Ready-to-use Cetrorelix Injection App 20130303464 - Patel; Pankaj ; et al. | 2013-11-14 |
| Stable Temsirolimus Composition And Process Of Preparing Same App 20120252835 - RAJPUT; Harsh ; et al. | 2012-10-04 |
| In-vitro method for testing bioequivalence of iron-sucrose formulation Grant 8,058,076 - Shah , et al. November 15, 2 | 2011-11-15 |
| Novel Dosage Form Of Paliperidone And Process For Preparing The Same App 20110177137 - Chauhan; Vijaysinh Vanvirsinh ; et al. | 2011-07-21 |
| Stable Oxaliplatin Composition For Parenteral Administration App 20100267824 - Sehgal; Ashish ; et al. | 2010-10-21 |
| In-vitro Method For Testing Bioequivalence Of Iron-sucrose Formulation App 20100248376 - SHAH; Samir ; et al. | 2010-09-30 |
| Sustained Release Dosage Form Of Phenothiazine Derivatives Containing Channelizer App 20100178333 - Mandal; Jayanta Kumar ; et al. | 2010-07-15 |
| Taxane Derivative Composition App 20090275647 - SEHGAL; Ashish ; et al. | 2009-11-05 |
| Controlled Release Formulation Comprising Anti-epileptic Drugs App 20090196923 - Mandal; Jayanta Kumar ; et al. | 2009-08-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 